Changes in Hospitalization and Infection Burden in Patients with Multiple Myeloma Before and During the COVID-19 Pandemic.

Publication date: Jun 14, 2026

Background: The increasing incidence and improved survival rates of multiple myeloma (MM) have led to a growing healthcare burden, particularly in terms of hospitalizations. In addition, infection-related complications remain a major cause of morbidity and mortality in these patients. The impact of infection control measures implemented during the COVID-19 pandemic on hospitalization patterns in MM is not well-established. Methods: We conducted a retrospective observational study including all hospital admissions of patients with MM in a tertiary hospital in Spain across three different periods: 2008, 2018, and May 2020 to April 2021 (COVID-19 pandemic period). We analyzed the proportion of admissions, cumulative length of stay, causes of hospitalization, and infection-related complications. Results: The proportion of hospitalizations due to MM increased significantly from 14% in 2008 to 29. 8% in 2018 (p

Open Access PDF

Concepts Keywords
Healthcare COVID-19
Myeloma epidemiolo
Pneumonia healthcare utilization
hospitalization
infection
multiple myeloma
nosocomial pneumonia
respiratory infections

Semantics

Type Source Name
disease MESH Infection
disease MESH Multiple Myeloma
disease MESH COVID-19 Pandemic
disease MESH respiratory infections
disease MESH nosocomial pneumonia
drug DRUGBANK Coenzyme M
disease MESH hematologic malignancy
disease MESH non Hodgkin lymphoma
disease MESH dys
disease MESH included
disease MESH leukemia
disease MESH hematologic diseases
disease MESH Myelodysplastic syndromes
disease MESH chronic myelomonocytic leukemia
disease MESH neoplasms
disease MESH Lymphoproliferative disorders
disease MESH AHDs
disease MESH monoclonal gammopathies
disease MESH amyloidosis
disease MESH MGs
disease MESH IBM
disease MESH AHD
disease MESH Renal failure
disease MESH Hypercalcemia
disease MESH Urinary tract infection
disease MESH Catheter related infection
disease MESH Acute kidney injury
disease MESH Venous thromboembolism
disease MESH syndrome
drug DRUGBANK Daratumumab
disease MESH pathological fractures
disease MESH anemia
disease MESH CAR
disease MESH Dis
disease MESH Lymphoma
disease MESH death
disease MESH injury

Original Article

(Visited 5 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *